Communicable diseases intelligence quarterly report最新文献

筛选
英文 中文
Revised surveillance case definitions: Shiga toxin-producing Escherichia coli (STEC). 修订监测病例定义:产志贺毒素大肠杆菌(STEC)。
Communicable diseases intelligence quarterly report Pub Date : 2016-09-30 DOI: 10.33321/cdi.2016.40.39
{"title":"Revised surveillance case definitions: Shiga toxin-producing Escherichia coli (STEC).","authors":"","doi":"10.33321/cdi.2016.40.39","DOIUrl":"10.33321/cdi.2016.40.39","url":null,"abstract":"","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"E367"},"PeriodicalIF":0.0,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34798705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surveillance of adverse events following immunisation in Australia annual report, 2014. 2014年澳大利亚年度报告中免疫接种后不良事件监测。
Communicable diseases intelligence quarterly report Pub Date : 2016-09-30 DOI: 10.33321/cdi.2016.40.41
Aditi Dey, Han Wang, Helen E Quinn, Richard Hill, Kristine K Macartney
{"title":"Surveillance of adverse events following immunisation in Australia annual report, 2014.","authors":"Aditi Dey, Han Wang, Helen E Quinn, Richard Hill, Kristine K Macartney","doi":"10.33321/cdi.2016.40.41","DOIUrl":"10.33321/cdi.2016.40.41","url":null,"abstract":"<p><p>This report summarises Australian passive surveillance data for adverse events following immunisation (AEFI) for 2014 reported to the Therapeutic Goods Administration for 2014 and describes reporting trends over the 15-year period 1 January 2000 to 31 December 2014. There were 3,087 AEFI records for vaccines administered in 2014; an annual AEFI reporting rate of 13.2 per 100,000 population. There was a decline of 5% in the overall AEFI reporting rate in 2014 compared with 2013. This decline in reported adverse events in 2014 compared with the previous year was mainly attributable to fewer reports following the human papillomavirus (HPV) vaccine as it was the 2nd year of the extension of the National HPV Vaccination Program to males. AEFI reporting rates for most vaccines were lower in 2014 compared with 2013. The most commonly reported reactions were injection site reaction (27%), pyrexia (18%), rash (16%), vomiting (9%), headache (7%), and syncope (5%). The majority of AEFI reports described non-serious events while 7% (n=211) were classified as serious. There were 5 deaths reported with no clear causal relationship with vaccination found.</p>","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"E377-E390"},"PeriodicalIF":0.0,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34799286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A brief overview of influenza surveillance systems in Australia, 2015. 2015年澳大利亚流感监测系统简要概述
Communicable diseases intelligence quarterly report Pub Date : 2016-09-30 DOI: 10.33321/cdi.2016.40.35
Sheena G Sullivan, Jane Raupach, Lucinda J Franklin, Kate Pennington, Christina Bareja, Rachel de Kluyver
{"title":"A brief overview of influenza surveillance systems in Australia, 2015.","authors":"Sheena G Sullivan, Jane Raupach, Lucinda J Franklin, Kate Pennington, Christina Bareja, Rachel de Kluyver","doi":"10.33321/cdi.2016.40.35","DOIUrl":"10.33321/cdi.2016.40.35","url":null,"abstract":"","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"E351-E355"},"PeriodicalIF":0.0,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34798702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Australian childhood immunisation coverage, 1 January to 31 December cohort, assessed as at 31 March 2016. 截至2016年3月31日评估的1月1日至12月31日队列澳大利亚儿童免疫接种覆盖率。
Communicable diseases intelligence quarterly report Pub Date : 2016-09-30 DOI: 10.33321/cdi.2016.40.45
Alexandra Hendry
{"title":"Australian childhood immunisation coverage, 1 January to 31 December cohort, assessed as at 31 March 2016.","authors":"Alexandra Hendry","doi":"10.33321/cdi.2016.40.45","DOIUrl":"10.33321/cdi.2016.40.45","url":null,"abstract":"","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"E444-E445"},"PeriodicalIF":0.0,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34799290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paediatric Active Enhanced Disease Surveillance inaugural annual report, 2014. 儿科主动增强疾病监测首次年度报告,2014年。
Communicable diseases intelligence quarterly report Pub Date : 2016-09-30 DOI: 10.33321/cdi.2016.40.42
Yvonne A Zurynski, Jocelynne E McRae, Helen E Quinn, Nicholas J Wood, Kristine K Macartney
{"title":"Paediatric Active Enhanced Disease Surveillance inaugural annual report, 2014.","authors":"Yvonne A Zurynski, Jocelynne E McRae, Helen E Quinn, Nicholas J Wood, Kristine K Macartney","doi":"10.33321/cdi.2016.40.42","DOIUrl":"10.33321/cdi.2016.40.42","url":null,"abstract":"<p><strong>Introduction: </strong>The Paediatric Active Enhanced Disease Surveillance (PAEDS) network is a hospital-based active surveillance system employing prospective case ascertainment of selected uncommon vaccine preventable diseases and potential adverse events following immunisation (AEFI). PAEDS enhances other Australian surveillance systems by providing prospective detailed clinical and laboratory data for the same child.</p><p><strong>Methods: </strong>Specialist surveillance nurses screen hospital admissions, emergency department records, laboratory and other data, to prospectively identify hospitalised children aged under 15 years in 5 paediatric tertiary referral hospitals in New South Wales, Victoria, South Australia, Western Australia and Queensland. Standardised protocols and case definitions are used across all sites. Conditions under surveillance include vaccine preventable diseases: acute flaccid paralysis, varicella, pandemic and seasonal influenza and pertussis, and potential AEFIs: febrile seizures and intussusception. PAEDS also conducts surveillance for acute childhood encephalitis.</p><p><strong>Results: </strong>Since August 2007, PAEDS has recruited a total of 6,227 hospitalised cases in total, for all conditions. From January to December 2014, there were 1,220 cases recruited across all conditions. Key outcomes include: enhanced acute flaccid paralysis surveillance to reach World Health Organization targets; supporting varicella and influenza vaccination in children; confirmation of a known low risk of febrile seizures following the 1st dose of measles-mumps-rubella vaccine but no increased risk of febrile seizures after measles-mumps-rubella-varicella vaccine, and a slightly increased risk of developing intussusception 1-7 days after rotavirus vaccination in infants aged less than 3 months. Acute childhood encephalitis data facilitated rapid investigation and response to the enterovirus 71 outbreak in 2013-2014.</p><p><strong>Conclusions: </strong>PAEDS provides unique policy-relevant data. This is the first of planned PAEDS annual reports to Communicable Diseases Intelligence.</p>","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"E391-E400"},"PeriodicalIF":0.0,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34799287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of Australia's polio surveillance. 澳大利亚脊髓灰质炎监测回顾。
Communicable diseases intelligence quarterly report Pub Date : 2013-06-30 DOI: 10.33321/cdi.2013.37.21
Beverley J Paterson, David N Durrheim
{"title":"Review of Australia's polio surveillance.","authors":"Beverley J Paterson, David N Durrheim","doi":"10.33321/cdi.2013.37.21","DOIUrl":"10.33321/cdi.2013.37.21","url":null,"abstract":"<p><p>With eradication almost within reach, the importance of detecting every poliomyelitis case has taken on additional significance. The selected surveillance strategy must be effective and efficient. A review of polio surveillance in Australia was conducted to consider whether current strategies were optimal. Document review and semi-structured key informant interviews were used to conduct the review. Interviews were recorded, transcribed and thematically analysed. The review was an iterative process with feedback on the findings sought from interviewees. Since Western Pacific Regional polio-elimination status was certified, one imported adult case was detected in 2007 in Australia, with no evidence of further transmission, and no Australian paediatric cases identified. Respondents reported that: it was not possible to prevent importations; paediatric cases were more likely to be identified than adult cases; and there may be a low level of suspicion among clinicians. Case detection and outbreak mitigation were considered key reasons to undertake polio surveillance. While Australia has not achieved one of the key World Health Organization (WHO) surveillance targets, this did not compromise Australias polio-free status. Identified issues with polio surveillance were the potential for an importation with high attendant investigation and containment costs, low stool sample collection rates, and the opportunity to improve safeguards around the importation and laboratory storage of biological samples containing poliovirus. The review found strong support for ongoing polio surveillance, particularly to detect imported cases and to demonstrate commitment to maintaining a polio-free region. Existing polio surveillance strategies were considered appropriate for Australia.</p>","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"E149-55"},"PeriodicalIF":0.0,"publicationDate":"2013-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40272987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adolescent school-based vaccination in Australia. 澳大利亚青少年以学校为基础的疫苗接种。
Communicable diseases intelligence quarterly report Pub Date : 2013-06-30 DOI: 10.33321/cdi.2013.37.22
Kirsten Ward, Helen Quinn, Michael Bachelor, Vicki Bryant, Sue Campbell-Lloyd, Angela Newbound, Megan Scully, Rosalind Webby, Peter B McIntyre
{"title":"Adolescent school-based vaccination in Australia.","authors":"Kirsten Ward, Helen Quinn, Michael Bachelor, Vicki Bryant, Sue Campbell-Lloyd, Angela Newbound, Megan Scully, Rosalind Webby, Peter B McIntyre","doi":"10.33321/cdi.2013.37.22","DOIUrl":"10.33321/cdi.2013.37.22","url":null,"abstract":"<p><p>Adolescents have become an increasingly prominent target group for vaccination in Australia and other developed countries. Over the past decade, voluntary school-based vaccination programs have evolved to become the primary method of delivering adolescent vaccines funded under Australia's National Immunisation Program (NIP). These programs operate at a state and territory level and offer NIP vaccines to adolescents in specific school grades using local teams of trained vaccine providers. This paper summarises the current operation of voluntary school-based vaccination programs in Australia. Information was obtained through a literature review, semi-structured interviews with those managing and implementing school-based vaccination programs in each jurisdiction and a review of program resources. Available coverage data was obtained from each state or territory. Vaccines are delivered at the school, during school hours, and typically target late primary or early secondary school grades. Written parental consent is required for any vaccine to be administered. Operation of the programs is influenced by various factors at the school and provider level. Despite variability in program implementation, collection and analysis of coverage data, comparable coverage has been achieved across all states and territories. Coverage is higher than that reported by other countries where adolescent vaccines are mandated for school entry or available only through community vaccination providers. Voluntary school-based vaccination programs are an established mechanism for the delivery of adolescent vaccines in Australia and vaccines offered will continue to evolve in light of national recommendations. Current gaps in evidence include a detailed understanding of the influence of procedural factors on uptake, the best ways to maximise consent form return and, standardisation of coverage data reporting.</p>","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"E156-67"},"PeriodicalIF":0.0,"publicationDate":"2013-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40273435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2012. 补充报告:2012年1月1日至6月30日澳大利亚7岁以下儿童免疫接种后不良事件监测。
Communicable diseases intelligence quarterly report Pub Date : 2013-06-30 DOI: 10.33321/cdi.2013.37.18
Deepika Mahajan, Jane Cook, Aditi Dey, Kristine Macartney, Rob Menzies
{"title":"Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2012.","authors":"Deepika Mahajan, Jane Cook, Aditi Dey, Kristine Macartney, Rob Menzies","doi":"10.33321/cdi.2013.37.18","DOIUrl":"10.33321/cdi.2013.37.18","url":null,"abstract":"","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"E130-4"},"PeriodicalIF":0.0,"publicationDate":"2013-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40272984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Annual report of the Australian National Enterovirus Reference Laboratory 2012. 澳大利亚国家肠道病毒参考实验室2012年年度报告。
Communicable diseases intelligence quarterly report Pub Date : 2013-06-30 DOI: 10.33321/cdi.2013.37.14
Jason Roberts, Linda Hobday, Aishah Ibrahim, Thomas Aitken, Bruce Thorley
{"title":"Annual report of the Australian National Enterovirus Reference Laboratory 2012.","authors":"Jason Roberts, Linda Hobday, Aishah Ibrahim, Thomas Aitken, Bruce Thorley","doi":"10.33321/cdi.2013.37.14","DOIUrl":"10.33321/cdi.2013.37.14","url":null,"abstract":"<p><p>In 2012 no cases of poliomyelitis were reported through clinical surveillance in Australia, and poliovirus was not detected through virological surveillance. Australia conducts surveillance for cases of acute flaccid paralysis (AFP) in children less than 15 years as the main mechanism to monitor its polio-free status in accordance with World Health Organization (WHO) recommendations. Cases of AFP in children are notified to the Australian Paediatric Surveillance Unit or the Paediatric Active Enhanced Disease Surveillance System. In 2012 Australia reported 1.2 non-polio AFP cases per 100,000 children, meeting the WHO performance criterion for a sensitive system for the fifth year in a row. However the faecal specimen collection rate from AFP cases was 29%, which was well below the WHO target of 80%. Virological surveillance for poliovirus consists of two components. Firstly, the Enterovirus Reference Laboratory Network of Australia (ERLNA) reports on the typing of enteroviruses detected in or isolated from clinical specimens. Secondly, environmental surveillance is conducted at sentinel sites. These surveillance systems are co-ordinated by the National Enterovirus Reference Laboratory (NERL).</p>","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"E97-E104"},"PeriodicalIF":0.0,"publicationDate":"2013-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40273438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the threat of chikungunya virus emergence in Australia. 评估基孔肯雅病毒在澳大利亚出现的威胁。
Communicable diseases intelligence quarterly report Pub Date : 2013-06-30 DOI: 10.33321/cdi.2013.37.19
Elvina Viennet, Katrina Knope, Helen M Faddy, Craig R Williams, David Harley
{"title":"Assessing the threat of chikungunya virus emergence in Australia.","authors":"Elvina Viennet, Katrina Knope, Helen M Faddy, Craig R Williams, David Harley","doi":"10.33321/cdi.2013.37.19","DOIUrl":"10.33321/cdi.2013.37.19","url":null,"abstract":"<p><strong>Background: </strong>Chikungunya virus (CHIKV) is a major threat to Australia given the distribution of competent vectors, and the large number of travellers returning from endemic regions. We describe current knowledge of CHIKV importations into Australia, and quantify reported viraemic cases, with the aim of facilitating the formulation of public health policy and ensuring maintenance of blood safety.</p><p><strong>Methods: </strong>Cases reported to the National Notifiable Disease Surveillance System (NNDSS) from 2002 to 2012 were analysed by place, month of acquisition, and place of residence. Rates of chikungunya importation were estimated based on reported cases and on the numbers of short-term movements.</p><p><strong>Results: </strong>Between 2002 and 2012, there were 168 cases of chikungunya virus (CHIKV) imported into Australia. Victoria and New South Wales had the largest number of notifications. The main sources were Indonesia, India and Malaysia. The number of cases increased from 2008 to reach a peak in 2010 (n=64; 40%). Although Indonesia accounted for the majority of CHIKV notifications in Australia, travel from India had the highest CHIKV importation rate (number of imported cases per 100,000 travellers).</p><p><strong>Conclusions: </strong>The Australian population is increasingly at risk from CHIKV. Arrivals from endemic countries have increased concurrently with vector incursions via imported goods, as well as via local movement from the Torres Strait to North Queensland ports. An outbreak of CHIKV could have a significant impact on health, the safety of the blood supply and on tourism. Case and vector surveillance as well as population health responses are crucial for minimising any potential impact of CHIKV establishment in Australia.</p>","PeriodicalId":350023,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":" ","pages":"E136-43"},"PeriodicalIF":0.0,"publicationDate":"2013-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40272985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信